Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review

Overview of attention for article published in BMC Nephrology, January 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 47 Mendeley
citeulike: 1 CiteULike

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 24,444 followers.

Let's go back to the dawn of the renal career for many of us. A nice reference (using irbesartan, which has been proven in RCTs to reduce need for dialysis for patients with DM) is this one: https://t.co/Bnxiv0loE3 Also this systematic review https://t.co

26 Apr 2018

Reply Repost Favourite

New atUMCG: Economic evaluations of angiotensin-converting enzyme inhibitors and angiot... http://t.co/mKtLcF2B8b http://t.co/W6irMJ7pbM

15 Jan 2014

Reply Repost Favourite

Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2... http://t.co/DxFSZobPeP

15 Jan 2014

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.